Research Snapshot: Genetic abnormality may predict outcomes in Ewing sarcoma
The findings could ultimately help clinicians personalize clinical-decision-making by predicting how a patient’s tumor might respond to cancer therapies.
The findings could ultimately help clinicians personalize clinical-decision-making by predicting how a patient’s tumor might respond to cancer therapies.
The study points to a new therapeutic strategy to reverse chemotherapy resistance in non-small cell lung cancer.
The biomaterial will have a range of applications in many types of dynamic biological systems and environments.
By exploring pathways that fuel the syndrome in mice, the study could contribute to new multimodal treatment approaches for cancer cachexia.
The findings could help develop new treatments to overcome resistance to chemotherapy.
Research from the Cardio-Oncology Symposium has been published in the American Heart Journal Plus: Cardiology Research and Practice.
The findings indicate that two DNA-damaging compounds may be able to overcome resistance to drugs used to treat advanced-stage prostate cancer.
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
Researchers identified a novel mechanism in the epigenome that could pave the way to develop new therapies for multiple myeloma.
UF Health Cancer Center researchers discovered a role of a protein in regulating genes that affect the immune system response to multiple myeloma.